QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 as-part-of-nabriva-therapeutics-cash-preservation-plan-the-companys-board-decided-to-terminate-all-non-essential-employees-to-execute-the-wind-down-of-its-operations-nabriva-said-it-largely-completed-the-planned-workforce-reduction-in-q1-2023

-NT 10Q

 stocks-that-hit-52-week-lows-on-monday

Companies That Fell Through 52-Week Lows Monday During Monday's morning trading, 14 companies set new 52-week lows.

 why-spruce-biosciences-shares-are-trading-higher-by-100-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic r...

 stocks-that-hit-52-week-lows-on-friday

  During Friday's trading, 71 companies set new 52-week lows.

 reported-earlier-nabriva-therapeutics-provides-corporate-update

-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations-   -Company To Continue Work With Torreya Capital...

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 75 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 89 companies set new 52-week lows.

 nabriva-therapeutics-announces-topline-results-from-phase-1-trial-of-xenleta-in-adult-patients-with-cystic-fibrosis

Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovat...

 nabriva-therapeutics-to-shift-focus-to-sivextro-will-reduce-headcount-by-40

Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovat...

 nabriva-therapeutics-q3-eps-421-misses-402-estimate-sales-920m-miss-1067m-estimate

Nabriva Therapeutics (NASDAQ:NBRV) reported quarterly losses of $(4.25) per share which missed the analyst consensus estimate o...

 earnings-scheduled-for-november-10-2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 930 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  Wednesday's session saw 361 companies set new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 1076 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 340 stocks hit new 52-week lows.

 why-knowbe4-shares-jumped-over-28-here-are-79-biggest-movers-from-yesterday

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 429 stocks made new 52-week lows.

 why-virios-therapeutics-is-trading-lower-by-over-71-here-are-55-stocks-moving-in-mondays-mid-day-session

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION